ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $790,000 | +58.6% | 89,909 | +21.8% | 0.00% | 0.0% |
| Q3 2016 | $498,000 | +101.6% | 73,836 | +6.4% | 0.00% | – |
| Q2 2016 | $247,000 | -56.7% | 69,415 | -64.1% | 0.00% | -100.0% |
| Q1 2016 | $570,000 | -27.9% | 193,335 | +3.1% | 0.00% | 0.0% |
| Q4 2015 | $791,000 | -21.3% | 187,521 | -14.9% | 0.00% | 0.0% |
| Q3 2015 | $1,005,000 | +8.5% | 220,379 | +71.7% | 0.00% | 0.0% |
| Q2 2015 | $926,000 | +41.6% | 128,365 | +44.6% | 0.00% | 0.0% |
| Q1 2015 | $654,000 | -88.9% | 88,770 | -92.9% | 0.00% | -83.3% |
| Q4 2014 | $5,916,000 | +31.6% | 1,250,851 | -0.7% | 0.01% | +50.0% |
| Q3 2014 | $4,495,000 | -28.6% | 1,259,176 | -8.8% | 0.00% | -33.3% |
| Q2 2014 | $6,298,000 | -21.6% | 1,381,344 | -19.2% | 0.01% | -25.0% |
| Q1 2014 | $8,038,000 | -5.9% | 1,710,264 | +0.3% | 0.01% | 0.0% |
| Q4 2013 | $8,540,000 | -31.0% | 1,704,503 | -14.3% | 0.01% | -33.3% |
| Q3 2013 | $12,370,000 | +3729.7% | 1,988,735 | +2691.5% | 0.01% | – |
| Q2 2013 | $323,000 | – | 71,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |